Which has the lower trailing P/E, DVA or HALO?

DVA has the lower trailing P/E: DVA trades at 15.95 and HALO at 32.84. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DVA or HALO?

Over the past five years, HALO grew revenue faster — DVA at a 3.91% CAGR versus HALO at 32.18%.

Is DVA or HALO more profitable?

HALO runs the higher net margin — DVA at 6.05% versus HALO at 24.86%.

How have DVA and HALO total returns compared?

Over the past 10 years, DVA delivered 10.80% and HALO delivered 24.30% annualized total return. Past performance doesn't predict future results.

DaVita Inc. (DVA) vs Halozyme Therapeutics, Inc. (HALO)

A side-by-side comparison of DaVita Inc. and Halozyme Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DVA

DaVita Inc.

$11.65B

$181.47HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT

HALO

Halozyme Therapeutics, Inc.

$13.05B

$110.02HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT

Total return — DVA vs HALO

growth of $100 · dividends reinvested · last 10y

DVA +169.9% (+10.4%/yr)HALO +779.9% (+24.3%/yr)HALO compounded faster over this window

DVA HALO

DVA vs HALO: by the numbers

•HALO is the larger company ($13.05B vs $11.65B market cap).
•DVA trades at the lower trailing earnings multiple (15.95 vs 32.84 P/E), one valuation lens rather than an overall verdict.
•HALO converts more revenue to profit (24.86% vs 6.05% net margin).
•HALO grew revenue faster over the past five years (32.18% vs 3.91% CAGR).

Metrics side by side

Valuation

Metric	DVA	HALO
P/E ratio	15.95	32.84
Forward P/E	12.28	13.08
PEG ratio	1.93	1.43
P/S ratio	0.83	7.84
P/B ratio	N/A	90.91
EV / EBITDA	7.72	14.25
FCF yield	13.82%	6.18%

Profitability

Metric	DVA	HALO
Gross margin	31.02%	78.18%
Operating margin	15.06%	56.77%
Net margin	6.05%	24.86%
ROE	N/A	288.13%
ROIC	11.18%	27.42%

Growth (annualized)

Metric	DVA	HALO
Revenue CAGR (5Y)	3.91%	32.18%
EPS CAGR (5Y)	8.25%	22.68%
FCF CAGR (5Y)	7.44%	40.08%
Total return CAGR (5Y)	9.22%	22.18%

Frequently asked

Which has the lower trailing P/E, DVA or HALO?: DVA has the lower trailing P/E: DVA trades at 15.95 and HALO at 32.84. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DVA or HALO?: Over the past five years, HALO grew revenue faster — DVA at a 3.91% CAGR versus HALO at 32.18%.
Is DVA or HALO more profitable?: HALO runs the higher net margin — DVA at 6.05% versus HALO at 24.86%.
How have DVA and HALO total returns compared?: Over the past 10 years, DVA delivered 10.80% and HALO delivered 24.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DVA analysis Full HALO analysis Interactive comparison tool

Dig into the metrics

DaVita P/E ratio Halozyme Therapeutics P/E ratio DaVita ROE Halozyme Therapeutics ROE DaVita operating margin Halozyme Therapeutics operating margin DaVita revenue growth Halozyme Therapeutics revenue growth DaVita free cash flow Halozyme Therapeutics free cash flow

DaVita & Halozyme Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.